Inhibition of PC-3 prostate cancer cell growth in vitro using both antisense oligonucleotides and taxol

Medical Oncology(2003)

引用 12|浏览6
暂无评分
摘要
Antisense oligonucleotides (oligos) directed against mRNA-encoding transforming growth factor-α (TGF-α) and the epidermal growth factor receptor (EGFR) have demonstrated in vitro and in vivo efficacy against prostate cancer tumor models. However, many therapeutic agents have increased effectiveness when given in combination with other more established agents. We evaluated the effectiveness of two oligos (3.32 and 6.64 µM/L) known to have significant activity against the PC-3 prostate cell line in combination therapy with the chemotherapeutic agent paclitaxel (Taxol) (2.5 and 5.0 nm). Therapy was evaluated when oligos and Taxol were administered either as (1) single agents, (2) simultaneously in a combined therapy, or (3) sequentially, a form of combination therapy with both agents being administered in a series.
更多
查看译文
关键词
Antisense oligonucleotides,prostate cancer,therapy,TGF-α,EGFR
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要